药品注册申请号:085970
申请类型:ANDA (仿制药申请)
申请人:SANDOZ
申请人全名:--
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 AMITRIPTYLINE HYDROCHLORIDE AMITRIPTYLINE HYDROCHLORIDE TABLET;ORAL 150MG No No AB 1977/11/21 -- Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2016/04/25 SUPPL-74(补充) Approval Labeling STANDARD
2014/07/17 SUPPL-72(补充) Approval Labeling STANDARD
2007/11/13 SUPPL-65(补充) Approval Labeling
2007/06/29 SUPPL-64(补充) Approval Labeling
2005/06/09 SUPPL-62(补充) Approval Labeling
2002/12/16 SUPPL-61(补充) Approval Manufacturing (CMC)
2001/06/25 SUPPL-60(补充) Approval Labeling
2001/03/23 SUPPL-59(补充) Approval Manufacturing (CMC)
2000/08/07 SUPPL-58(补充) Approval Labeling
1999/05/05 SUPPL-57(补充) Approval Manufacturing (CMC)
1998/05/28 SUPPL-56(补充) Approval Manufacturing (CMC)
1996/11/18 SUPPL-55(补充) Approval Manufacturing (CMC)
1995/04/10 SUPPL-54(补充) Approval Labeling
1995/02/01 SUPPL-53(补充) Approval Manufacturing (CMC)
1993/08/27 SUPPL-52(补充) Approval Labeling
1992/12/15 SUPPL-51(补充) Approval Labeling
1987/07/17 SUPPL-50(补充) Approval Manufacturing (CMC)
1987/07/17 SUPPL-48(补充) Approval Manufacturing (CMC)
1987/07/17 SUPPL-45(补充) Approval Manufacturing (CMC)
1987/07/17 SUPPL-44(补充) Approval Manufacturing (CMC)
1987/07/17 SUPPL-43(补充) Approval Manufacturing (CMC)
1987/07/17 SUPPL-42(补充) Approval Manufacturing (CMC)
1987/07/17 SUPPL-41(补充) Approval Manufacturing (CMC)
1987/04/27 SUPPL-49(补充) Approval Manufacturing (CMC)
1987/01/08 SUPPL-47(补充) Approval Manufacturing (CMC)
1987/01/08 SUPPL-46(补充) Approval Manufacturing (CMC)
1987/01/08 SUPPL-40(补充) Approval Manufacturing (CMC)
1985/03/22 SUPPL-36(补充) Approval Manufacturing (CMC)
1985/03/22 SUPPL-35(补充) Approval Manufacturing (CMC)
1984/01/25 SUPPL-34(补充) Approval Manufacturing (CMC)
1983/07/27 SUPPL-32(补充) Approval Manufacturing (CMC)
1983/07/27 SUPPL-30(补充) Approval Manufacturing (CMC)
1983/07/27 SUPPL-29(补充) Approval Manufacturing (CMC)
1983/03/21 SUPPL-28(补充) Approval Manufacturing (CMC)
1982/06/23 SUPPL-27(补充) Approval Manufacturing (CMC)
1982/06/23 SUPPL-24(补充) Approval Manufacturing (CMC)
1977/11/21 ORIG-1(原始申请) Approval
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:AMITRIPTYLINE HYDROCHLORIDE 剂型/给药途径:TABLET;ORAL 规格:150MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
085970 001 ANDA AMITRIPTYLINE HYDROCHLORIDE AMITRIPTYLINE HYDROCHLORIDE TABLET;ORAL 150MG Prescription No No AB -- SANDOZ
085968 005 ANDA AMITRIPTYLINE HYDROCHLORIDE AMITRIPTYLINE HYDROCHLORIDE TABLET;ORAL 150MG Prescription Yes No AB Approved Prior to Jan 1, 1982 SANDOZ
089399 006 ANDA AMITRIPTYLINE HYDROCHLORIDE AMITRIPTYLINE HYDROCHLORIDE TABLET;ORAL 150MG Prescription No No AB 1987/07/14 SUN PHARM INDS INC
040218 006 ANDA AMITRIPTYLINE HYDROCHLORIDE AMITRIPTYLINE HYDROCHLORIDE TABLET;ORAL 150MG Discontinued No No AB 1997/09/11 ENDO OPERATIONS
202446 006 ANDA AMITRIPTYLINE HYDROCHLORIDE AMITRIPTYLINE HYDROCHLORIDE TABLET;ORAL 150MG Prescription No No AB 2014/06/04 ACCORD HLTHCARE
210086 006 ANDA AMITRIPTYLINE HYDROCHLORIDE AMITRIPTYLINE HYDROCHLORIDE TABLET;ORAL 150MG Prescription No No AB 2017/10/06 ZYDUS PHARMS
213999 006 ANDA AMITRIPTYLINE HYDROCHLORIDE AMITRIPTYLINE HYDROCHLORIDE TABLET;ORAL 150MG Prescription No No AB 2021/02/19 MANKIND PHARMA
214548 006 ANDA AMITRIPTYLINE HYDROCHLORIDE AMITRIPTYLINE HYDROCHLORIDE TABLET;ORAL 150MG Prescription No No AB 2021/05/19 UNICHEM
212654 006 ANDA AMITRIPTYLINE HYDROCHLORIDE AMITRIPTYLINE HYDROCHLORIDE TABLET;ORAL 150MG Prescription No No AB 2021/09/29 AIPING PHARM INC
216243 006 ANDA AMITRIPTYLINE HYDROCHLORIDE AMITRIPTYLINE HYDROCHLORIDE TABLET;ORAL 150MG Prescription No No AB 2022/06/06 BRECKENRIDGE
215376 006 ANDA AMITRIPTYLINE HYDROCHLORIDE AMITRIPTYLINE HYDROCHLORIDE TABLET;ORAL 150MG Prescription No No AB 2023/05/01 RUBICON
217411 006 ANDA AMITRIPTYLINE HYDROCHLORIDE AMITRIPTYLINE HYDROCHLORIDE TABLET;ORAL 150MG Prescription No No AB 2023/05/19 RISING
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database